The DNA double-stranded break repair protein endo-exonuclease as a therapeutic target for cancer

Molecular Cancer Therapeutics

Volumn 3, Issue 8, 2004, Pages 911-919

  Chow, Terry Y K ^a,c   Alaoui Jamali, Moulay A ^b   Yeh, Chiaoli ^c   Yuen, Leonard ^c   Griller, David ^c  

^a MCGILL UNIVERSITY HEALTH CENTRE   (Canada)

^b MCGILL UNIVERSITY   (Canada)

^c INSTITUTE FOR RESEARCH IN IMMUNOLOGY AND CANCER   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN; DIMINAZENE ACETURATE; DISTAMYCIN A; DOUBLE STRANDED DNA; ETOPOSIDE; EXONUCLEASE; FLUOROURACIL; MITOMYCIN C; PENTAMIDINE; RNA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER CELL CULTURE; CANCER INHIBITION; CELL DEATH; CLONOGENIC ASSAY; CONTROLLED STUDY; CORRELATION ANALYSIS; CYTOTOXICITY; DNA CROSS LINKING; DNA STRAND BREAKAGE; DRUG POTENTIATION; DRUG SENSITIVITY; DRUG TARGETING; ENZYME ACTIVITY; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; LD 50; MOUSE; MYELOMA CELL; NONHUMAN; OPPORTUNISTIC INFECTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECEPTOR DOWN REGULATION; TUMOR MODEL;

ANIMALS; ANTIMETABOLITES, ANTINEOPLASTIC; ANTINEOPLASTIC AGENTS; ANTINEOPLASTIC AGENTS, PHYTOGENIC; CARCINOMA, LEWIS LUNG; CELL LINE, TUMOR; CELL SURVIVAL; CISPLATIN; COLORING AGENTS; DNA; DNA DAMAGE; DNA REPAIR; DOWN-REGULATION; DRUG EVALUATION, PRECLINICAL; ENDONUCLEASES; ETOPOSIDE; EXONUCLEASES; FLUOROURACIL; HELA CELLS; HUMANS; KINETICS; MICE; MITOMYCIN; NEOPLASMS; PENTAMIDINE; PLASMIDS; RECOMBINATION, GENETIC; RNA, SMALL INTERFERING; TETRAZOLIUM SALTS; THIAZOLES; TIME FACTORS;

EID: 4444292375     PISSN: 15357163     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (44)

1. Bertram JS. The molecular biology of cancer. Mol Aspects Med 2000; 21:167-223.
2. Gerdes AM. Cancer genetics. A review of oncological molecular biology seen in relation to the human genome. Ugeskr Laeger 2002;164: 2865-71.
3. Trimmer EE, Essigmann JM. Cisplatin. Essays Biochem 1999;34: 191-211.
4. Raymond E, Faivre S, Woynarowski JM, Chaney SG. Oxaliplatin: mechanism of action and antineoplastic activity. Semin Oncol 1998;25: 4-12.
5. Dronkert ML, Kanaar R. Repair of DNA interstrand cross-links. Mutat Res 2001;486:217-47.
6. Iyer L, Ratain MJ. Clinical pharmacology of camptothecins. Cancer Chemother Pharmacol 1998;42:S31-43.
7. Ewesuedo RB, Retain MJ. Topoisomerase I inhibitors. Oncologist 1997; 2:359-64.
8. Brozmanova J, Dudas A, Henriques JA. Repair of oxidative DNA damage - an important factor reducing cancer risk. Neoplasma 2001;48: 85-93.
9. Friedberg EC. How nucleotide excision repair protects against cancer. Nat Rev Cancer 2001;1:22-33.
10. van den Bosch M, Lohman PH, Pastink A. DNA double-strand break repair by homologous recombination. Biol Chem 2002;383:873-92.
11. Noguchi T, Shibata T, Fumoto S, Uchida Y, Mueller W, Takeno S. DNA-PKcs expression in esophageal cancer as a predictor for chemoradiation therapeutic sensitivity. Ann Surg Oncol 2002;9:1017-22.
12. Omori S, Takiguchi Y, Suda A, et al. Suppression of a DNA doublestrand break repair gene, Ku70, increases radio- and chemosensitivity in a human lung carcinoma cell line. DNA Repair 2002;1:299-310.
13. Bennett CB, Lewis AL, Baldwin KK, Resnick MA. Lethality induced by a single site-specific double-strand break in a dispensable yeast plasmid. Proc Natl Acad Sci USA 1993;90:5613-7.
14. Bennett CB, Westmoreland TJ, Snipe JR, Resnick MA. A double-strand break within a yeast artificial chromosome (YAC) containing human DNA can result in YAC loss, deletion or cell lethality. Mol Cell Biol 1996; 16:4414-25.
15. Fraser MJ. Endo-exonuclease: actions in the life and death of cells. Austin: R.G. Landes Co.; 1996.
16. Tomkinson AE, Linn S. Purification and properties of a single strand-specific endonuclease from mouse cell mitochondria. Nucleic Acids Res 1986;14:9579-93.
17. Couture C, Chow TY. Purification and characterization of a mammalian endo-exonuclease. Nucleic Acids Res 1992;20:4355-61.
18. Liu G, Lehnert S, Chow TY. Mammalian endo-exonuclease activity and its level in various radiation sensitive cell lines. Mutagenesis 1995;10:91-4.
19. Hildebrandt E, Boykin DW, Kumar A, Tidwell RR, Dykstra CC. Identification and characterization of an endo/exonuclease in Pneumocystis carinii that is inhibited by dicationic diarylfurans with efficacy against Pneumocystis pneumonia. J Eukaryot Microbiol 1998;45: 112-21.
20. Chow TY, Resnick MA. Purification and characterization of an endo-exonuclease from Saccharomyces cerevisiae that is influenced by the RAD52 gene. J Biol Chem 1987;262:17659-67.
21. Sadekova S, Chow TY. Over-expression of the NUD1-coded endo-exonuclease in Saccharomyces cerevisiae enhances DNA recombination and repair. Curr Genet 1996;30:50-5.
22. Semionov A, Cournoyer D, Chow TY. Transient expression of Saccharomyces cerevisiae endo-exonuclease NUD1 gene increases the frequency of extrachromosomal homologous recombination in mouse Ltk-fibroblasts. Mutat Res 1999;435:129-39.
23. Asefa B, Kauler P, Cournoyer D, Lehnert S, Chow TY. Genetic analysis of the yeast NUD1 endo-exonuclease: a role in the repair of DNA double-strand breaks. Curr Genet 1998;34:360-7.
24. Laemmli UK. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970;227:680-5.
25. Chow TY, Resnick MA. An endo-exonuclease activity of yeast that requires a functional RAD52 gene. Mol Gen Genet 1988;211:41-8.
26. Chow TY-K, Resnick MA. The identification of a deoxyribonuclease controlled by the RAD52 gene of Saccharomyces cerevisiae In: Friedberg EC, Bridges BA, editors. Cellular responses to DNA damage. New York: Alan R. Liss; 1983. p. 447-55.
27. Sadekova S, Lehnert S, Chow TY. Induction of PBP74/mortalin/ Grp75, a member of the hsp70 family, by low doses of ionizing radiation: a possible role in induced radioresistance. Int J Radiat Biol 1997;72: 653-60.
28. Niks M, Otto M. Towards an optimized MTT assay. J Immunol Methods 1990;130:149-51.
29. Chou TC, Motzer RJ, Tong Y, Bosl GJ. Computerized quantitation of synergism and antagonism of taxol, topotecan, and cisplatin against human teratocarcinoma cell growth: a rational approach to clinical protocol design. J Natl Cancer Inst 1994;86:1517-24.
30. Edwards KJ, Jenkins TC, Neidle S. Crystal structure of a pentamidine-oligonucleotide complex: implications for DNA-binding properties. Biochemistry 1992;31:7104-9.
31. Greenidge PA, Jenkins TC, Neidle S. DNA minor groove recognition properties of pentamidine and its analogs: a molecular modeling study. Mol Pharmacol 1993;43:982-8.
32. Boykin DW, Kumar A, Spychala J, et al. Dicationic diarylfurans as anti-Pneumocystis carinii agents. J Med Chem 1995;38:912-6.
33. Longley DB, Harkin DP, Johnston PG. 5-Fluorouracil: mechanisms of action and clinical strategies. Nat Rev Cancer 2003;3:330-8.
34. Chow TY, Fraser MJ. Purification and properties of single strand DNA-binding endo-exonuclease of Neurospora crassa. J Biol Chem 1983;258: 12010-8.
35. Koa H, Fraser MJ, Kafer E. Endo-exonuclease of Aspergillus nidulans. Biochem Cell Biol 1990;68:387-92.
36. Chow TY, Fraser MJ. The major intracellular alkaline deoxyribonuclease activities expressed in wild-type and Rec-like mutants of Neurospora crassa. Can J Biochem 1979;57:889-901.
37. Semionov A, Cournoyer D, Chow TY. The effect of the Saccharomyces cerevisiae endo-exonuclease NUD1 gene expression on the resistance of HeLa cells to DNA-damaging agents. Mutat Res 1999;433: 169-81.
38. Bornstein RS, Yarbro JW. An evaluation of the mechanism of action of pentamidine isethionate. J Surg Oncol 1970;2:393-8.
39. Bailly C, Perrine D, Lancelot JC, Saturnino C, Robba M, Waring MJ. Sequence-selective binding to DNA of bis(amidinophenoxy)alkanes related to propamidine and pentamidine. Biochem J 1997;323:23-31.
40. Pathak MK, Dhawan D, Lindner DJ, Borden EC, Farver C, Yi T. Pentamidine is an inhibitor of PRL phosphatases with anticancer activity. Mol Cancer Ther 2002;1:1255-64.
41. Hopfner KP, Karcher A, Craig L, Woo TT, Carney JP, Tainer JA. Structural biochemistry and interaction architecture of the DNA double-strand break repair Mre11 nuclease and Rad50-ATPase. Cell 2001; 105:473-85.
42. Honjo T, Kinoshita K, Muramatsu M. Molecular mechanism of class switch recombination: linkage with somatic hypermutation. Annu Rev Immunol 2002;20:165-96.
43. Dohjima T, Lee NS, Li H, Ohno T, Rossi JJ. Small interfering RNAs expressed from a PolIII promoter suppress the EWS/Fli-1 transcript in an Ewing sarcoma cell line. Mol Ther 2003;7:811-6.
44. Lee NS, Dohjima T, Bauer G, et al. Expression of small interfering RNAs targeted against HIV-1 rev transcripts in human cells. Nat Biotechnol 2002;20:500-5.